Skip to content

Study · Observational study · 2016

2 results

Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions.

Van Hout MC, Hearne E

Substance use & misuse15 Jan 2016Cited by 10 (Europe PMC)

PMID26771670 (opens in a new tab)DOI10.3109/10826084.2015.1082595 (opens in a new tab)PepBankPUB-26771670
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanObservational studyOther

    In online forum threads on female use of CJC‑1295, users said they chose it for weight loss, muscle enhancement, youthful skin, improved sleep and injury healing.

    In plain wordsIn online forum threads, women said they used CJC‑1295 for weight loss, muscle gain, younger-looking skin, better sleep and injury healing. These are user claims.

    Peptide
    CJC-1295 (with DAC)
    Outcome
    Not applicableReasons for female use of CJC-1295 in online forums
    Study

    n: not reported in source

    Outcome group
    Patterns of use · Whole body
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Choice to use CJC-1295 centered on weight loss, muscle enhancement, youthful skin, improved sleep, and injury healing.
    1 context sentence
    Summary · context
    Twenty-three discussion threads relating to female use of CJC-1295 formed the end data set, and analyzed using the Empirical Phenomenological Psychological method.
  2. 02HumanObservational studySafety outcome

    In online forum threads, users raised concerns about female consequences of CJC‑1295 use, including dosage estimation, cycling and long-term consequences.

    In plain wordsIn online forum threads, women raised concerns about dosing, cycling and long-term effects of CJC‑1295 use. These are user concerns, not measured harms.

    Peptide
    CJC-1295 (with DAC)
    Outcome
    Not applicableConcerns about female use of CJC-1295 in online forums
    Study

    n: not reported in source

    Outcome group
    Patterns of use · Whole body
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Concerns were described relating to female consequences of use given gender variations in growth hormone pulses affecting estimation of dosage, cycling, and long-term consequences.
    1 context sentence
    Summary · context
    Twenty-three discussion threads relating to female use of CJC-1295 formed the end data set, and analyzed using the Empirical Phenomenological Psychological method.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    9 Oct 2026, 18:17 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:13 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.